Products billed under this code include Cyclophosphamide, Cyclophosphamide (Ingenus).
Payment limit per 5 MG, by effective quarter, 2Q24 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Cyclophosphamide | BluePoint Laboratories | 68001-0564-22 | 200 | $93.00 |
| Cyclophosphamide | BluePoint Laboratories | 68001-0565-28 | 400 | $186.00 |
| Cyclophosphamide | Athenex Pharmaceutical Division, LLC | 70860-0218-10 | 400 | $186.00 |
| Cyclophosphamide | Dr. Reddy's Laboratories Inc. | 75907-0189-35 | 400 | $186.00 |
| Cyclophosphamide | Dr. Reddy's Laboratories Inc. | 75907-0190-07 | 200 | $93.00 |
| Cyclophosphamide | Dr. Reddy's Laboratories Inc. | 75907-0191-02 | 100 | $46.50 |
| Cyclophosphamide (Ingenus) | Ingenus Pharmaceuticals LLC | 50742-0519-02 | 100 | $46.50 |
| Cyclophosphamide (Ingenus) | Ingenus Pharmaceuticals LLC | 50742-0520-05 | 200 | $93.00 |
| Cyclophosphamide (Ingenus) | Ingenus Pharmaceuticals LLC | 50742-0521-10 | 400 | $186.00 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $0.465 | −$0.033 | 5 MG | Inj cyclophos dr reddys 5 mg | v1, posted September 17, 2026 |
| 3Q26 | $0.498 | −$0.005 | 5 MG | Inj cyclophos dr reddys 5 mg | v1, posted September 15, 2026 |
| 2Q26 | $0.503 | −$0.193 | 5 MG | Inj cyclophos dr reddys 5 mg | v1, posted September 15, 2026 |
| 1Q26 | $0.696 | −$0.088 | 5 MG | Inj cyclophos dr reddys 5 mg | v1, posted September 15, 2026 |
| 4Q25 | $0.784 | −$0.372 | 5 MG | Inj cyclophos dr reddys 5 mg | v1, posted September 8, 2026 |
| 3Q25 | $1.156 | −$0.606 | 5 MG | Inj cyclophos dr reddys 5 mg | v1, posted March 10, 2026 |
| 2Q25 | $1.762 | −$0.426 | 5 MG | Inj cyclophos dr reddys 5 mg | v1, posted March 10, 2026 |
| 1Q25 | $2.188 | +$1.263 | 5 MG | Inj cyclophosphamd (ingenus) | v1, posted December 19, 2025 |
| 4Q24 | $0.925 | +$0.136 | 5 MG | Inj cyclophosphamd (ingenus) | v1, posted June 11, 2025 |
| 3Q24 | $0.789 | −$0.192 | 5 MG | Inj cyclophosphamd (ingenus) | v1, posted June 11, 2025 |
| 2Q24 | $0.981 | – | 5 MG | Inj cyclophosphamd (ingenus) | v1, posted March 11, 2025 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
